In vivo analysis of FBXO45-mediated fibrosis and liver tumorigenesis in a chemically induced mouse model of hepatocellular carcinoma

STAR Protoc. 2023 Mar 17;4(1):102124. doi: 10.1016/j.xpro.2023.102124. Epub 2023 Feb 15.

Abstract

FBXO45, an E3 ubiquitin ligase highly expressed in liver tumors, is positively correlated with poor survival of hepatocellular carcinogenesis (HCC) patients, but whether FBXO45 drives HCC tumorigenesis remains largely unclear. Here, we describe a protocol that shortens the observation period for HCC tumorigenesis to assess the effects of FBXO45 in a DEN/CCl4-induced HCC mouse model. We describe steps for chemical induction of HCC in FBXO45-overexpressing mice, followed by tissue collection and pathology assessment via quantitative real-time PCR, histology, and immunohistochemistry. For complete details on the use and execution of this protocol, please refer to Lin et al. (2021).1.

Keywords: Cancer; Health Sciences; Microscopy; Model Organisms; Molecular Biology.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Carcinogenesis / genetics
  • Carcinoma, Hepatocellular* / chemically induced
  • Carcinoma, Hepatocellular* / genetics
  • Carcinoma, Hepatocellular* / pathology
  • Disease Models, Animal
  • F-Box Proteins* / genetics
  • Fibrosis
  • Humans
  • Liver Neoplasms* / chemically induced
  • Liver Neoplasms* / genetics
  • Mice

Substances

  • FBXO45 protein, human
  • F-Box Proteins